Literature DB >> 31127536

Developmental Phenotype of the Rare Case of DJ Caused by a Unique ADNP Gene De Novo Mutation.

Joseph Levine1,2, David Cohen3, Carole Herman4, Alain Verloes5, Vincent Guinchat3, Lautaro Diaz3, Cora Cravero3,6, Anne Mandel3, Illana Gozes7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31127536     DOI： 10.1007/s12031-019-01333-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN： 0895-8696            Impact factor:   3.444


× No keyword cloud information.
  47 in total

1.  Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.

Authors:  Daniel C Javitt; Robert W Buchanan; Richard S E Keefe; Robert Kern; Robert P McMahon; Michael F Green; Jeffrey Lieberman; Donald C Goff; John G Csernansky; Joseph P McEvoy; Fred Jarskog; Larry J Seidman; James M Gold; David Kimhy; Karen S Nolan; Deanna S Barch; M Patricia Ball; James Robinson; Stephen R Marder
Journal:  Schizophr Res       Date:  2011-12-12       Impact factor: 4.939

2.  Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.

Authors:  N Amram; G Hacohen-Kleiman; S Sragovich; A Malishkevich; J Katz; O Touloumi; R Lagoudaki; N C Grigoriadis; E Giladi; A Yeheskel; M Pasmanik-Chor; Y Jouroukhin; I Gozes
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

3.  Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain.

Authors:  Narendra K Sharma; Niroj K Sethy; Ram Niwas Meena; Govindsamy Ilavazhagan; Mainak Das; Kalpana Bhargava
Journal:  Peptides       Date:  2011-03-29       Impact factor: 3.750

4.  Davunetide improves spatial learning and memory in Alzheimer's disease-associated rats.

Authors:  Jun Zhang; Shu-Yu Wei; Li Yuan; Lin-Lin Kong; Sheng-Xiao Zhang; Zhao-Jun Wang; Mei-Na Wu; Jin-Shun Qi
Journal:  Physiol Behav       Date:  2017-02-28

5.  Cloning and characterization of the human activity-dependent neuroprotective protein.

Authors:  R Zamostiano; A Pinhasov; E Gelber; R A Steingart; E Seroussi; E Giladi; M Bassan; Y Wollman; H J Eyre; J C Mulley; D E Brenneman; I Gozes
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

6.  Acute behavioral crises in psychiatric inpatients with autism spectrum disorder (ASD): recognition of concomitant medical or non-ASD psychiatric conditions predicts enhanced improvement.

Authors:  Vincent Guinchat; Cora Cravero; Lautaro Diaz; Didier Périsse; Jean Xavier; Claire Amiet; Isabelle Gourfinkel-An; Nicolas Bodeau; Lee Wachtel; David Cohen; Angèle Consoli
Journal:  Res Dev Disabil       Date:  2015-01-07

7.  NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Regina Pikman; Eliezer Giladi; Annie Andrieux; Illana Gozes
Journal:  Peptides       Date:  2010-04-22       Impact factor: 3.750

8.  Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.

Authors:  Gal Hacohen-Kleiman; Shlomo Sragovich; Gidon Karmon; Andy Y L Gao; Iris Grigg; Metsada Pasmanik-Chor; Albert Le; Vlasta Korenková; R Anne McKinney; Illana Gozes
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

9.  The autism spectrum phenotype in ADNP syndrome.

Authors:  Anne B Arnett; Candace L Rhoads; Kendra Hoekzema; Tychele N Turner; Jennifer Gerdts; Arianne S Wallace; Sandra Bedrosian-Sermone; Evan E Eichler; Raphael A Bernier
Journal:  Autism Res       Date:  2018-08-14       Impact factor: 5.216

10.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.

Authors:  Brian J O'Roak; Laura Vives; Santhosh Girirajan; Emre Karakoc; Niklas Krumm; Bradley P Coe; Roie Levy; Arthur Ko; Choli Lee; Joshua D Smith; Emily H Turner; Ian B Stanaway; Benjamin Vernot; Maika Malig; Carl Baker; Beau Reilly; Joshua M Akey; Elhanan Borenstein; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Jay Shendure; Evan E Eichler
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962
View more
  6 in total

1.  Vineland Adaptive Behavior Scale in a Cohort of Four ADNP Syndrome Patients Implicates Age-Dependent Developmental Delays with Increased Impact of Activities of Daily Living.

Authors:  Joseph Levine; Fahed Hakim; R Frank Kooy; Illana Gozes
Journal:  J Mol Neurosci       Date:  2022-08-03       Impact factor: 2.866

2.  Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond.

Authors:  Oxana Kapitansky; Eliezer Giladi; Iman Jaljuli; Stefan Bereswill; Markus M Heimesaat; Illana Gozes
Journal:  J Neural Transm (Vienna)       Date:  2020-02-18       Impact factor: 3.575

Review 3.  The ADNP Syndrome and CP201 (NAP) Potential and Hope.

Authors:  Illana Gozes
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

Review 4.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

5.  Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting.

Authors:  Oxana Kapitansky; Gidon Karmon; Shlomo Sragovich; Adva Hadar; Meishar Shahoha; Iman Jaljuli; Lior Bikovski; Eliezer Giladi; Robert Palovics; Tal Iram; Illana Gozes
Journal:  Cells       Date:  2020-10-19       Impact factor: 6.600

6.  Autism and COVID-19: A Case Series in a Neurodevelopmental Unit.

Authors:  Leslie Nollace; Cora Cravero; Alice Abbou; Brice Mazda-Walter; Alexandre Bleibtreu; Nathalie Pereirra; Myriam Sainte-Marie; David Cohen; Marianna Giannitelli
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.